Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 803,276 |
|
|||||
| News | - | ||||||
| Day High | 34.46 | Low High |
|||||
| Day Low | 32.6101 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Arvinas Inc | ARVN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.90 | 2.69% | 34.35 | 18:55:15 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 33.42 | 32.6101 | 34.46 | 34.29 | 33.45 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,508 | 803,276 | US$ 33.94 | US$ 27,261,043 | - | 13.57 - 53.08 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:01:53 | formt | 100 | US$ 34.35 | USD |
Arvinas (ARVN) Options Flow Summary
Arvinas Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.33B | 68.08M | - | 78.5M | -367.3M | -5.39 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Arvinas News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARVN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 39.12 | 39.34 | 32.6101 | 35.49 | 713,028 | -4.77 | -12.19% |
| 1 Month | 44.75 | 44.85 | 32.6101 | 38.14 | 521,587 | -10.40 | -23.24% |
| 3 Months | 37.25 | 53.08 | 32.6101 | 44.37 | 767,133 | -2.90 | -7.79% |
| 6 Months | 16.30 | 53.08 | 13.57 | 35.76 | 782,446 | 18.05 | 110.74% |
| 1 Year | 28.34 | 53.08 | 13.57 | 31.91 | 597,377 | 6.01 | 21.21% |
| 3 Years | 64.47 | 108.465 | 13.57 | 47.94 | 499,354 | -30.12 | -46.72% |
| 5 Years | 20.74 | 108.465 | 13.57 | 47.10 | 485,728 | 13.61 | 65.62% |
Arvinas Description
| Arvinas Inc is a United States-based private biopharmaceutical company focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. Its pipeline candidates include metastatic castration-resistant prostate cancer, metastatic ER-breast cancer, additional oncology indications, tauopathies, and other neurodegenerative diseases. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766. |
